{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-094557","form_type":"8-K","ticker":null,"cik":"0001213660","company_name":"BIMI Holdings Inc.","filed_at":"2023-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.446974+00:00","generated_at":"2026-06-07T14:43:24.312924+00:00","sec_items":["2.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BIMI issues 5M shares to Chairman after Phenix Bio earns $2.5M profit target in Q2 2023","bullets":["Phenix Bio achieved aggregate net profit of at least $2.5M in Q2 2023, triggering earnout shares.","5,000,000 common shares issued to Chairman Fnu Oudom on Dec 6, 2023 as earnout consideration.","Total acquisition price for Phenix: $180K cash plus 5.27M shares; additional 5M shares issued on milestone.","Transaction closed March 15, 2023; performance condition met in Q2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-094557","json":"https://secwatch.observer/filing/0001213900-23-094557.json","markdown":"https://secwatch.observer/filing/0001213900-23-094557.md","text":"https://secwatch.observer/filing/0001213900-23-094557.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/0001213900-23-094557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/ea189792-8k_bimiinter.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T14:43:24.312924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dbd057a24d229c8d08f82b9d32fd6fdc0aa58d61","claim":"BIMI Holdings Inc. completed an acquisition involving Fnu Oudom for $180,000 in cash plus 5,270,000 shares of the Company's common stock (closed 2023-03-15).","evidence_excerpt":"the transaction closed effective March 15, 2023 when 100% of equity interests in Phenix were transferred to the Company and the closing consideration was paid. The aggregate purchase price for the equity interests in Phenix was $180,000 in cash, which has been paid, plus 5,270,000 shares of the Company’s common stock","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023094557/0001213900-23-094557-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Fnu Oudom"},{"label":"Consideration","value":"$180,000 in cash plus 5,270,000 shares of the Company's common stock"},{"label":"Closing","value":"2023-03-15"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}